PT72002B - Procede pour la preparation de nouveaux azepinoindoles a effet pharmaceutique - Google Patents

Procede pour la preparation de nouveaux azepinoindoles a effet pharmaceutique

Info

Publication number
PT72002B
PT72002B PT72002A PT7200280A PT72002B PT 72002 B PT72002 B PT 72002B PT 72002 A PT72002 A PT 72002A PT 7200280 A PT7200280 A PT 7200280A PT 72002 B PT72002 B PT 72002B
Authority
PT
Portugal
Prior art keywords
azepinoindoles
preparation
new
alkyl
pharmaceutical effect
Prior art date
Application number
PT72002A
Other languages
English (en)
French (fr)
Other versions
PT72002A (fr
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT72002A publication Critical patent/PT72002A/pt
Publication of PT72002B publication Critical patent/PT72002B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT72002A 1979-11-02 1980-10-31 Procede pour la preparation de nouveaux azepinoindoles a effet pharmaceutique PT72002B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH985279 1979-11-02

Publications (2)

Publication Number Publication Date
PT72002A PT72002A (fr) 1980-11-01
PT72002B true PT72002B (fr) 1981-12-17

Family

ID=4356374

Family Applications (1)

Application Number Title Priority Date Filing Date
PT72002A PT72002B (fr) 1979-11-02 1980-10-31 Procede pour la preparation de nouveaux azepinoindoles a effet pharmaceutique

Country Status (13)

Country Link
US (1) US4478750A (pt)
EP (1) EP0028381B1 (pt)
JP (1) JPS5675493A (pt)
AT (1) ATE12641T1 (pt)
AU (1) AU6401480A (pt)
DE (1) DE3070467D1 (pt)
DK (1) DK465380A (pt)
ES (1) ES8205800A1 (pt)
FI (1) FI803356A7 (pt)
IL (1) IL61382A (pt)
NZ (1) NZ195423A (pt)
PT (1) PT72002B (pt)
ZA (1) ZA806741B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649553A5 (de) * 1982-05-06 1985-05-31 Sandoz Ag Azepinoindole und verfahren zu deren herstellung.
DE3229215A1 (de) * 1982-08-05 1984-02-09 Basf Ag, 6700 Ludwigshafen 1-(halogenalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung
US4748247A (en) * 1986-10-21 1988-05-31 American Home Products Corporation 2-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]alkyl]alkyl]pyrido- and pyrazino-indole-1,3-dione derivatives as histamine H1 antagonists
FR2663935A1 (fr) * 1990-06-27 1992-01-03 Adir Nouveaux 1,2,3,4,5,6-hexahydroazepino [4,5-b] indoles et 1,2,3,4-tetrahydrobethacarbolines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9025890D0 (en) * 1990-11-28 1991-01-09 Lilly Industries Ltd Pharmaceutical compounds
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US7030109B2 (en) 1999-07-19 2006-04-18 Pharmacia & Upjohn Company 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
MY122278A (en) 1999-07-19 2006-04-29 Upjohn Co 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
WO2002004456A1 (en) 2000-07-06 2002-01-17 Pharmacia & Upjohn Company SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES
AR035493A1 (es) 2000-09-20 2004-06-02 Upjohn Co Derivados de azepino (4,5b) indolina sustituidos, composicion farmaceutica y el uso de dichos derivados para preparar un medicamento
WO2003014118A1 (en) * 2001-08-08 2003-02-20 Pharmacia & Upjohn Company THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
EP3519816A4 (en) 2016-09-29 2020-05-06 The Regents of the University of California Compounds for increasing neural plasticity
CN113784962B (zh) 2019-02-27 2025-04-25 加利福尼亚大学董事会 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH445509A (de) * 1964-12-03 1967-10-31 Geigy Ag J R Verfahren zur Herstellung von neuen Indolderivaten
US3839357A (en) * 1966-05-10 1974-10-01 Upjohn Co 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
US3553232A (en) * 1967-08-25 1971-01-05 Upjohn Co 4-(1,4,5,6-tetrahydroazepine(4,5-b)indole-3(2h)-yl)butyrophenones
US3652588A (en) * 1969-10-23 1972-03-28 Upjohn Co 6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles

Also Published As

Publication number Publication date
EP0028381A3 (en) 1981-07-22
ES496451A0 (es) 1982-06-16
NZ195423A (en) 1984-07-06
JPS5675493A (en) 1981-06-22
DE3070467D1 (en) 1985-05-15
US4478750A (en) 1984-10-23
FI803356L (fi) 1981-05-03
ZA806741B (en) 1982-05-26
FI803356A7 (fi) 1981-05-03
PT72002A (fr) 1980-11-01
ATE12641T1 (de) 1985-04-15
DK465380A (da) 1981-05-03
IL61382A (en) 1984-02-29
ES8205800A1 (es) 1982-06-16
EP0028381B1 (en) 1985-04-10
AU6401480A (en) 1981-05-07
IL61382A0 (en) 1980-12-31
EP0028381A2 (en) 1981-05-13

Similar Documents

Publication Publication Date Title
PT72002B (fr) Procede pour la preparation de nouveaux azepinoindoles a effet pharmaceutique
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
FI852974L (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
AR240909A2 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
NO893205L (no) Kjemiske forbindelser.
PT94731A (pt) Processo de producao de pirimidina-nucleosidos antivirais, dos seus intermediarios e de composicoes farmaceuticas
DE3887614D1 (de) Substituierte Cycloalkanole.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
PT91574A (pt) Procede de preparation de n-cycloalkyle benzyamines utiles comme medicaments
FI872555A0 (fi) Antiallergiska och antiinflammatoriska aemnen.
ATE70274T1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
DK322588A (da) Cycloalkylamider af 6-substituerede (8beta)-1-alkylergoliner og fremgangsmaade til fremstilling af saadanne forbindelser
MA19604A1 (fr) Procede de preparation de nouvelles triazoloquinazolones et leurs sels
FR2780404B1 (fr) Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
DE3375784D1 (en) 1,3,4,6,7,11b-hexahydro-7-aryl-2h-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation
DE58903671D1 (de) Schwefelhaltige oximether und diese enthaltende fungizide.
ATE129250T1 (de) Carboxamidderivate.
MX9202994A (es) Derivados de 2-aminoacetamida.
FR2593810B1 (fr) Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant
BG33281A3 (bg) Метод за получаване на 2-(2-хлор-4-циклопропил- фенил-имино)-имидазодидин,неговите присъединителни соли и лекарствени средства,съдържащи тези съединения
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
PT87069A (pt) Process for the preparation of 3-(6:-methoxy-2:-naphthylmethyl)-2,4-pentanedione
ATE17244T1 (de) Biologisch wirksame, heterobicyclische hydroximidate und thiolhydroximidate und deren carbamatester-derivate.